6 completed, 1 withdrawn. 4 Phase 2, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 3 | 2 | Completed 1, Withdrawn 1 |
| Phase 4 | 1 | Completed 1 |
Follow Dr. Frank Behrens: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Bronchipret on Antiviral Immune Response in Patients With Mild COVID-19 Bronchipret - COVID-19 | Phase 2 | Completed | Dr. Frank Behrens | 21 | 2022-01-14 | 2024-08-28 |
| Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients Polyglucoferron, Ferric carboxymaltose, Ferrous Sulfate - Iron Deficiency Anemia | Phase 3 | Withdrawn | Dr. Frank Behrens | 2020-05-15 | 2024-08-28 | |
| Prevention of Paclitaxel-induced Neuropathic Pain in Patients With Planned Paclitaxel Chemotherapy (PrevTel) Telmisartan tablets - Neuropathic Pain, Chemotherapy Effect | Phase 2 | Completed | Dr. Frank Behrens | 35 | 2020-04-09 | 2024-08-28 |
| Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients Tofacitinib, Etanercept - Rheumatic Arthritis | Phase 4 | Completed | Dr. Frank Behrens | 92 | 2019-11-04 | 2024-08-28 |
| Preliminary Efficacy and Safety of Apremilast in the Treatment of Acne Conglobata Apremilast - Acne Conglobata | Phase 2 | Completed | Dr. Frank Behrens | 1 | 2019-10-09 | 2022-03-02 |
| Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA Methotrexate, Ustekinumab, Placebo - Psoriatic Arthritis | Phase 3 | Completed | Dr. Frank Behrens | 186 | 2016-12-15 | 2022-03-02 |
| TMP001 in Relapsing-remitting Multiple Sclerosis TMP001 - Remitting-Relapsing Multiple Sclerosis | Phase 2 | Completed | Dr. Frank Behrens | 9 | 2015-08-01 | 2018-11-21 |
Acne Conglobata (1) · Anemia, Iron-Deficiency (1) · Arthritis, Psoriatic (1) · Breast Neoplasms (1) · COVID-19 (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Neuralgia (1) · Ovarian Neoplasms (1) · Pain (1) · Rheumatic Fever (1)
5-(tetradecyloxy)-2-furancarboxylic acid (1) · Etanercept (1) · Methotrexate (1) · Receptor, Endothelin A (1) · Telmisartan (1) · Ustekinumab (1) · apremilast (1) · ferric carboxymaltose (1) · ferrous sulfate (1) · tarenflurbil (1) · thyme extract and ivy extract drug combination (1) · tofacitinib (1)
Germany (7)
Andreas Pinter, MD (1) · Frank Behrens, MD (1) · Harald Burkhardt, MD (1) · Kai Zacharowski, Prof. MD (1) · Martin Sebastian, MD (1) · Stephan Schaefer, MD (1) · Ulf Ziemann, MD (1)